IVOG - Vanguard S&P Mid-Cap 400 Growth ETF
|Ex-Dividend Date||Dec 22, 2020|
|Trading Day||April 19|
|Day's Range||200.48 - 202.72|
|52-Week Range||113.51 - 203.39|
The investment seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization growth stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the S&P MidCap 400® Growth Index, which represents the growth companies, as determined by the index sponsor, of the S&P MidCap 400 Index. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
|Asset Class |
|Inception Date |
Sep 9, 2010
|Ticker Symbol |
|Index Tracked |
S&P Mid-Cap 400 Growth Index
Top 10 Holdings12.86% of assets
|Charles River Laboratories||CRL||1.35%|
|Dec 22, 2020||$1.32||Dec 28, 2020|
|Dec 16, 2019||$1.722||Dec 19, 2019|
|Dec 13, 2018||$1.194||Dec 18, 2018|
|Dec 19, 2017||$1.2364||Dec 22, 2017|
|Dec 20, 2016||$1.158||Dec 27, 2016|
|Dec 17, 2015||$1.034||Dec 23, 2015|
This Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) has hit a new 52-week high. Are more gains in store?
PTH and IVOG saw massive trading volumes in yesterday trading session.